Parse Biosciences Extends Global Reach with India-based Spinco Biotech Partnership November 7, 2023 SEATTLE — November 7, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with India-based Spinco Biotech to further extend its reach in Asia. This is Parse’s latest expansion in the APAC region following an agreement last year with Research Instruments Pte Ltd to distribute […] Read More
Julie Gerardi Joins Parse Biosciences as Vice President of Business Development September 18, 2023 Veteran biotech executive to head commercial partnerships to accelerate drug discovery SEATTLE — September 19, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice president of business development. Gerardi will lead commercial strategy for large scale applications of […] Read More
Parse Biosciences Launches CRISPR Detect June 8, 2023 SEATTLE — June 8, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today the launch of CRISPR Detect, enabling single cell pooled CRISPR screens at unprecedented scale. Bulk pooled CRISPR screening has been a valuable tool to understand gene function on a genome scale. Adding single cell […] Read More
Parse Biosciences Expands Global Access to Israel May 16, 2023 SEATTLE — May 16, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Israel-based Ornat Biochemicals and Laboratory Equipment to extend Parse’s reach in the Middle East. “The past year has represented a considerable leap forward for Parse, with demand growing significantly for our […] Read More
Parse Biosciences and Human Cell Atlas Partner to Help Map Human Cells April 27, 2023 Partnership provides Human Cell Atlas collaborating members benefits of Parse’s single cell solutions SEATTLE — April 27, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the company has partnered with the international Human Cell Atlas (HCA) consortium, a global collaboration of researchers developing comprehensive reference maps […] Read More
Parse Biosciences Announces Evercode TCR and Gene Capture February 7, 2023 New immune profiling and enrichment capabilities expand applications and facilitate scalability HOLLYWOOD, FLA. (AGBT GENERAL MEETING) — February 7, 2023 — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ TCR and Gene Capture. These new solutions expand the Parse Biosciences portfolio to address higher […] Read More
Parse Biosciences to Participate in Canaccord Genuity Investor Conference November 8, 2022 MEDIA ADVISORY CEO and co-founder Alex Rosenberg, Ph.D. joining panel discussion at November 17 event in New York WHAT:Senior executives from Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, will participate in the Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum. The one-day event will profile public and […] Read More
Parse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis October 26, 2022 New Platform to Lower Barriers to Adoption of Single Cell RNA Sequencing. ASHG Annual Meeting, Los Angeles, CA, October 26, 2022 – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud […] Read More
Parse Biosciences Releases Whole Transcriptome Version 2 Chemistry with Marked Performance Enhancements August 30, 2022 Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE, August 30, 2022 – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products. With substantial gains in transcript and gene detection […] Read More
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea June 6, 2022 With products now available in South Korea, partnership broadens access to single cell genomics research in Asia Seattle, WA. (June 6, 2022) – Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of […] Read More
